仅用ThinPrep玻片评估甲状腺FNA充分性标准
将充分性阈值降至任何滤泡细胞且取消6组每组10细胞要求,不影响检测性能;核增大、淡染、核沟及组织细胞样细胞与恶性相关。
要点
- 仅ThinPrep评估时降低充分性阈值不影响检测性能
- 取消6组每组至少10细胞要求不影响检测性能
- 核增大、淡染、核沟及组织细胞样细胞与恶性相关
核心结论
- 仅用ThinPrep评估甲状腺FNA时,降低充分性阈值并取消6组每组至少10细胞要求,若缺乏恶性细胞学特征则不影响检测性能。
研究设计与样本
- 回顾性分析2010至2015年所有甲状腺FNA操作中与手术标本匹配的病例,对初始无诊断病例评估细胞计数和细胞学特征,由2名病理医师重新分类并与手术结果比较。
主要发现
- 重新分类观察者间一致性中等(k=0.57),共识分类为无诊断48例(33%)、良性72例(49%)、意义未明的不典型24例(16%)、可疑恶性2例(1%)。
- 将诊断阈值降至任何滤泡细胞时敏感性92%、特异性60%、阳性预测值59%、阴性预测值92%、假阴性率7.7%;初始诊断病例分别为93%、58%、59%、93%、7.7%。
- 纳入细胞数>60但缺乏6组每组至少10细胞的病例不影响检测性能。
- 初始无诊断FNA中核增大、淡染、核沟及组织细胞样细胞与恶性相关。
关键数值与推荐
- 仅ThinPrep评估时,降低充分性阈值至任何滤泡细胞且取消6组每组至少10细胞要求,若缺乏恶性相关细胞学特征则不影响检测性能。
临床怎么用
- 仅用ThinPrep评估甲状腺FNA时,可考虑降低充分性阈值并取消6组每组至少10细胞要求,但需评估恶性相关细胞学特征。
局限性
- 回顾性分析,仅纳入与手术标本匹配的病例,初始无诊断病例样本量有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Adequacy criteria for thyroid fine-needle aspiration (FNA) recommended by The Bethesda System for Reporting Thyroid Cytopathology (TBS) were developed with smears, but they are commonly applied to ThinPreps (TPs). This study evaluated adequacy in TPs at different diagnostic thresholds. METHODS: All FNA procedures performed between 2010 and 2015 with matched surgical specimens were analyzed. Cell counts and cytological features were evaluated in all initially nondiagnostic (ND) cases. ND cases were reclassified into TBS categories by 2 pathologists, and the results were compared with surgical outcomes. RESULTS: One hundred forty-six of the 151 cases initially classified as ND were available for review, and they had a mean cell count of 60.5 (standard deviation, 71.4). Interobserver agreement on the reclassification of ND cases was moderate (k = 0.57), and consensus yielded 48 ND cases (33%), 72 benign cases (49%), 24 cases of atypia of undetermined significance (16%), and 2 cases suspicious for malignancy (1%). Lowering the diagnostic threshold to any follicular cells yielded a sensitivity of 92%, a specificity of 60%, a positive predictive value of 59%, a negative predictive value of 92%, and a false-negative rate of 7.7%, whereas the values for the initially diagnostic cases were 93%, 58%, 59%, 93%, and 7.7%, respectively. Including cases with >60 cells but lacking 6 groups containing at least 10 cells did not affect test performance. Nuclear enlargement, pallor, grooves, and the presence of histiocytoid cells in initially ND FNA correlated with malignancy. CONCLUSIONS: In thyroid FNA examined with TP only, lowering the adequacy threshold and eliminating the requirement of 6 groups of at least 10 cells did not significantly affect test performance if cytological features associated with malignancy were absent. Cancer Cytopathol 2017;125:534-43. © 2017 American Cancer Society.
引用
- Vivero M, Renshaw AA, Krane JF, et al. Adequacy criteria for thyroid FNA evaluated by ThinPrep slides only. Cancer Cytopathol. 2017. PMID: 28388017. doi:10.1002/cncy.21858
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。